Ketoacid Analogues Intradialytic Effect on Inflammation

NCT06392516 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2024-04-30

No results posted yet for this study

Summary

this study tries to measure the effect of intradialytic ketoacid analogues on inflammatory parameters

Conditions

  • Hemodialysis Complication

Interventions

DRUG

Ketoacid

250 ml ketoacid two hours before the hemodialysis session ended

Sponsors & Collaborators

  • RSUP Fatmawati

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2024-08-31
Completion
2024-09-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392516 on ClinicalTrials.gov